What if melatonin changes children's REM sleep?

Case Review:

9-year-old male with autism spectrum disorder referred for polysomnography for sleep-onset insomnia. Reports nightly melatonin 3 mg at 20:00 for 6 months; no other prescription sleep meds. Vitals: T 36.7°C, HR 82 bpm. PSG: total sleep time within expected range, REM percentage 17%; exam: no respiratory distress. Pertinent negative: no recent fever or daytime seizures.

Question:

Which explanation best accounts for the PSG finding of slightly reduced REM percentage in this child?

• A. Night-to-night variability only; single-night PSG cannot be interpreted.

• B. Exogenous melatonin acting as a chronobiotic can shift sleep timing and modestly change REM proportion.

• C. Obstructive sleep apnea suppressing REM in children.

• D. Melatonin causes global sedation that increases non-REM N3 at the expense of REM.

• E. Antipsychotic medication causing REM suppression.

Description:

Exogenous melatonin primarily signals the circadian system (a chronobiotic effect) through melatonin receptors; shifting internal sleep timing can redistribute sleep stages so a single-night recording shows a modestly lower REM percentage rather than widespread disruption. This mechanism explains the small REM reduction without major changes in total sleep time or breathing on PSG. Test your understanding of this mechanism with practicetest.

Clinical Insight:

The same pattern (small REM differences without broad PSG changes) may appear when treating delayed sleep phase or using melatonin in children with neurodevelopmental conditions; always consider comorbid psychiatric diagnoses and concurrent meds as confounders. Management focuses on phenotype-guided use (timing, dose, pairing with behavioral strategies) and monitoring for developmental concerns. Review the key takeaways with studysheet.

Why this matters:

Melatonin use in children is common and rising; recognizing how it may subtly alter sleep-stage distribution is important for counseling families and for exam-style clinical reasoning.

Quick take-away:

1. Identify the sleep phenotype (circadian delay vs behavioral insomnia).

2. Prioritize behavioral interventions.

3. If melatonin is used, record dose/timing and reassess with history or repeat testing.

Common pitfalls to watch for:

• Assuming over-the-counter melatonin is uniformly safe and inert in children.

• Ignoring timing and formulation when judging effectiveness.

• Interpreting a single-night PSG as definitive without clinical context.

Order targeted review questions and a spaced set of flashcards to reinforce recognition and management of melatonin-related sleep findings.